Pharmaceuticals News and Research

RSS

Laureate Pharma signs development and manufacturing agreement to develop fusion protein products

Laureate Pharma, Inc., a full-service biopharmaceutical development and protein production company, today announced that it has signed a new Biopharmaceutical Development and Manufacturing Agreement with an undisclosed client.

22 Oct 2009

Auxano point-of-care indicator system for dry eye syndrome

Auxano Diagnostics, LLC, a subsidiary of Auxano Biomedical, LLC, has announced the application of the company’s breakthrough wound care technology to the treatment of dry eye syndrome (DES) with the Auxano point-of-care indicator system.

21 Oct 2009

Swine flu vaccines arrive at health departments, hospitals and community vaccinator facilities

The Swine Flu (H1N1)Vaccine is starting to arrive at health departments, hospitals, and community vaccinator facilities.

21 Oct 2009

Shire to file a Biologics License Application for REPLAGAL with the FDA

Shire plc, the global specialty biopharmaceutical company, announces plans to file a Biologics License Application (BLA) with the U.S. Food and Drug Administration (FDA) for REPLAGAL(R) (agalsidase alfa), its enzyme replacement therapy for Fabry disease, by the end of the year.

21 Oct 2009

King Pharmaceuticals receives FDA complete response letter for CorVue NDA

King Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) issued a complete response letter regarding the New Drug Application (NDA) for CorVue™ (binodenoson) for injection.

21 Oct 2009

DUSA Pharmaceuticals finds place in Deloitte's Technology Fast 500 list for second consecutive year

DUSA Pharmaceuticals, Inc.(R)( )(Nasdaq: DUSA), a specialty pharmaceutical company focused on dermatology, announced today that it has been named to Deloitte's Technology Fast 500 list. For the second consecutive year, Deloitte recognized DUSA as one of the Top 500 fastest growing technology, media, telecommunications and life sciences companies in North America in terms of percentage revenue growth over a five year period.

21 Oct 2009

First Edition: October 21, 2009

As Senate Democrats wrestle with a doctor payment bill separate from sweeping health care reform proposals, the public plan, public opinion and health care costs continue to be a Capitol Hill focus.

21 Oct 2009

ICON reports its financial results for the third quarter ended September 30, 2009

ICON, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for its third quarter ended September 30, 2009.

21 Oct 2009

Philadelphia's Franklin Institute to exhibit Gunther von Hagens' Body Worlds 2 & The Brain

Gunther von Hagens' Body Worlds 2 & The Brain made its debut at Philadelphia's Franklin Institute on October 17, and will be one of many points of interest for visitors eager to explore the area's vast array of scientific treasures.

21 Oct 2009

APP Pharmaceuticals to launch Chlorothiazide Sodium for Injection

APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market Chlorothiazide Sodium for Injection, USP. APP expects to launch Chlorothiazide Sodium for Injection, USP in the fourth quarter of 2009.

21 Oct 2009

Comparative Effectiveness Research: One way to beat the competition

A higher percentage of companies are using Comparative Effectiveness Research to help with pricing and reimbursement decisions, according to new research from Cutting Edge Information.

21 Oct 2009

Otsuka Pharmaceutical acquires newly issued common shares of MethylGene

Otsuka Pharmaceutical Co., Ltd., a wholly owned subsidiary of Otsuka Holdings Co., Ltd. based in Japan, announces that on October 20, 2009, pursuant to the private placement disclosed on October 14, 2009, it acquired 3,686,182 newly issued common shares of MethylGene Inc. Following the closing of this private placement, Otsuka Pharmaceutical owns 9.12% of the issued and outstanding common shares of MethylGene.

21 Oct 2009

Weekly Digest releases report on investment opportunities in connection with the H1N1 outbreak

Weekly Digest (http://www.bullmarket.com/digest), a free investment research publication, announced the publication of a special report on investment opportunities in connection with the H1N1 "Swine Flu" Outbreak, including updated outlooks for GlaxoSmithKline, Sanofi-Aventis, Novartis, Baxter International, Roche Holding and several others.

21 Oct 2009

Interim study analysis comparing MENOPUR with rFSH in GnRH Antagonist IVF cycles

Ferring Pharmaceuticals presented an interim study analysis indicating that MENOPUR® (menotropins for injection, USP) is effective in in vitro fertilization (IVF) cycles using a gonadotropin-releasing hormone (GnRH) antagonist. The results were presented in a poster at the 65th Annual Meeting of the American Society for Reproductive Medicine (ASRM) in Atlanta, October 17-21, 2009.

21 Oct 2009

U.S. Pharmacopeial fellowships awarded to 6 students

New research focused on the quality of key medicines and their use as well as increasingly popular botanicals is being sponsored by the U.S. Pharmacopeial (USP) Convention under its 2009� Fellowship Program.

21 Oct 2009

AlphaDetail adds two new features to its suite of tracking services

AlphaDetail, an innovator in pharmaceutical marketing research, is pleased to introduce two new features to its suite of tracking services: AlphaLink and AlphaMonitor.

21 Oct 2009

D2 Pharma Consulting develops "REMS Challenges and Real World Solutions" White Paper

D2 Pharma Consulting LLC (D2) is a best-in-class national consulting company that works with pharmaceutical and biotech manufacturers on the implementation of REMS compliant distribution programs, in addition to other commercialization activities. D2 structures REMS distribution programs on behalf of their clients that leverage supply chain efficiencies while complying with FDA mandates.

21 Oct 2009

Manhattan Scientifics enters into a non-binding LOI with Edward R. Flynn

Manhattan Scientifics announced today that it has entered into a non-binding letter of intent (LOI) with Edward R. Flynn, Ph.D. and his company, Senior Scientific, LLC, to acquire all the manufacturing and marketing rights, together with all commercial rights associated with Dr. Flynn’s patents and IP in the emerging field of nanomedicine.

21 Oct 2009

Unaudited financial results for the quarter ended August 31, 2009 from Sinobiopharma

Sinobiopharma, Inc. is pleased to present the following highlights from the unaudited financial results for the first quarter ended August 31, 2009.

21 Oct 2009

Logical Therapeutics to present its clinical study results on LT-NS001

Logical Therapeutics, Inc. (Logical), a biopharmaceutical company focused on developing products that treat medical conditions associated with inflammation, has been selected to present the results of its clinical study comparing the gastrointestinal (GI) safety of its lead product LT-NS001, vs. naproxen at the American College of Gastroenterology's (ACG) Annual Scientific Meeting on October 27, 2009.

21 Oct 2009

Pharmaceuticals News and Research

Laureate Pharma signs development and manufacturing agreement to develop fusion protein products

Auxano point-of-care indicator system for dry eye syndrome

Swine flu vaccines arrive at health departments, hospitals and community vaccinator facilities

Shire to file a Biologics License Application for REPLAGAL with the FDA

King Pharmaceuticals receives FDA complete response letter for CorVue NDA

DUSA Pharmaceuticals finds place in Deloitte's Technology Fast 500 list for second consecutive year

First Edition: October 21, 2009

ICON reports its financial results for the third quarter ended September 30, 2009

Philadelphia's Franklin Institute to exhibit Gunther von Hagens' Body Worlds 2 & The Brain

APP Pharmaceuticals to launch Chlorothiazide Sodium for Injection

Comparative Effectiveness Research: One way to beat the competition

Otsuka Pharmaceutical acquires newly issued common shares of MethylGene

Weekly Digest releases report on investment opportunities in connection with the H1N1 outbreak

Interim study analysis comparing MENOPUR with rFSH in GnRH Antagonist IVF cycles

U.S. Pharmacopeial fellowships awarded to 6 students

AlphaDetail adds two new features to its suite of tracking services

D2 Pharma Consulting develops "REMS Challenges and Real World Solutions" White Paper

Manhattan Scientifics enters into a non-binding LOI with Edward R. Flynn

Unaudited financial results for the quarter ended August 31, 2009 from Sinobiopharma

Logical Therapeutics to present its clinical study results on LT-NS001

Oxygen Measurement eBook - Easily Understand Dissolved Oxygen Measurement eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring